首页> 外文期刊>Journal of nanoscience and nanotechnology >Study of Fe3O4-PPy Core-Shell Nanocomposite in the Diagnosis of Tumor Markers in the Tissues of Early Gastric Cancer Patients
【24h】

Study of Fe3O4-PPy Core-Shell Nanocomposite in the Diagnosis of Tumor Markers in the Tissues of Early Gastric Cancer Patients

机译:Fe3O4-PPY核心壳纳米复合材料在早期胃癌患者组织肿瘤标志物诊断中的研究

获取原文
获取原文并翻译 | 示例
       

摘要

In order to study Fe3O4-Polypyrrole (Fe3O4-PPy) core-shell nanocomposite in the diagnosis of tumor markers in the diseased gastric tissues of early cancer patients, a total of 160 cases of patients, who were confirmed as early gastric cancerby gastroscopy or postoperative pathology at a designated hospital of the study from December 2014 to December 2018, were selected as research objects and were divided into two groups of observation and control group with 80 cases in each group. For each patient in the two groups, two piecesof diseased gastric tissue were firstly taken through gastroscopy; then the observation group applied Fe3O4-PPy with the particle diameter of 150-350 nm as carrier to detect the contents of carbohydrate antigen 19-9 (CA19-9), alpha-fetoprotein (AFP), carbohydrate antigen242 (CA242), carcinoembryonic antigen (CEA) and carbohydrate antigen 72-4 (CA72-4) in the diseased gastric tissue, while the control group directly detected the contents of corresponding tumor markers; after the detections, the sensitivity, specificity and diagnostic efficiency of each markerin the two groups of patients were calculated, and receiver operating characteristics (ROC) curves with the areas under the curves (AUC) were drawn to analyze the correlation between the level of Fe3O4-PPy and the detection efficiency of gastric cancer markers. The resultsshow that the detection sensitivity (82.17%, 80.32%, 79.48%, 84.63%, and 85.66%) and specificity (76.75%, 79.66%, 81.07%, 83.47%, and 85.24%) of CA19-9, AFP, CA242, CEA, and CA72-4 in the tumor tissue of patients in observation group for the diagnosis of early gastric cancer are higherthanthe sensitivity (78.66%, 79.25%, 76.18%, 82.11%, and 83.45%) and specificity (74.37%, 76.94%, 77.24%, 81.22%, and 81.59%) of that in control group with statistically significant differences (P 0.05). Therefore, it is believed that the Fe3O4-PPy is of greatsignificance for the detection of early gastric tumor markers in the tissues of patients with early gastric cancer, and has certain value for the auxiliary diagnosis of early gastric cancer and the observation of therapeutic effects. This study results provide a reference for the further researchesof Fe3O4-PPy in the diagnosis of tumor markers in patients with early gastric cancer.
机译:为了研究Fe3O4聚吡咯(Fe3O4-PPy)核壳纳米复合物在早期癌症患者病变胃组织中的肿瘤标记物诊断,从2014年12月到2018年12月,共有160例患者在该研究的指定医院通过胃镜或术后病理学确诊为早期胃癌,将患者分为观察组和对照组,每组80例。两组患者均首先通过胃镜取两片病变胃组织;观察组以粒径150-350nm的Fe3O4-PPy为载体,检测病变胃组织中糖类抗原19-9(CA19-9)、甲胎蛋白(AFP)、糖类抗原242(CA242)、癌胚抗原(CEA)和糖类抗原72-4(CA72-4)的含量,对照组直接检测相应肿瘤标志物的含量;检测后,计算两组患者中各标志物的敏感性、特异性和诊断效率,绘制受试者操作特征(ROC)曲线和曲线下面积(AUC),分析Fe3O4-PPy水平与胃癌标志物检测效率之间的相关性。结果表明,CA19-9、AFP、CA242、CEA、AFP的检测灵敏度分别为82.17%、80.32%、79.48%、84.63%和85.66%,特异性分别为76.75%、79.66%、81.07%、83.47%和85.24%,观察组患者肿瘤组织中CA72-4对早期胃癌的诊断敏感性(78.66%、79.25%、76.18%、82.11%和83.45%)和特异性(74.37%、76.94%、77.24%、81.22%和81.59%)均高于对照组,差异有统计学意义(P0.05)。因此,认为Fe3O4-PPy对早期胃癌患者组织中早期胃癌标志物的检测具有重要意义,对早期胃癌的辅助诊断和疗效观察具有一定价值。本研究结果为进一步研究Fe3O4-PPy对早期胃癌患者肿瘤标志物的诊断提供了参考。

著录项

  • 来源
  • 作者单位

    The First Endoscopic Diagnosis and Treatment Department The Second Affiliated Hospital of Xinjiang Medical University;

    The First Oncology Department The Affiliated Hospital of Traditional Chinese Medicine of Xinjiang Medical University;

    The First Endoscopic Diagnosis and Treatment Department The Second Affiliated Hospital of Xinjiang Medical University;

    The First Endoscopic Diagnosis and Treatment Department The Second Affiliated Hospital of Xinjiang Medical University;

    The First Endoscopic Diagnosis and Treatment Department The Second Affiliated Hospital of Xinjiang Medical University;

    The First Endoscopic Diagnosis and Treatment Department The Second Affiliated Hospital of Xinjiang Medical University;

    Department of Pathology The Second Affiliated Hospital of Xinjiang Medical University;

    The First Endoscopic Diagnosis and Treatment Department The Second Affiliated Hospital of Xinjiang Medical University;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 特种结构材料;
  • 关键词

    Fe3O4-PPy; Early Gastric Cancer; Core-Shell Nanocomposite; Tumor Marker;

    机译:Fe3O4-ppy;早期胃癌;核心壳纳米复合材料;肿瘤标志物;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号